MEC Plus

Neoadjuvant Updates
Neoadjuvant Updates
Tiffany Traina, MD
ILC, When Non-scary Becomes Scary
ILC, When Non-scary Becomes Scary
Jason Aboudi Mouabbi, MD
Escalation
Escalation
Quincy LaPlant, MD, PhD
De-Escalation
De-Escalation
Beryl McCormick, MD
Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes
Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes
Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM
Leveraging NCODA Resources to Manage Patients on Oral Oncolytics
Leveraging NCODA Resources to Manage Patients on Oral Oncolytics
Yarelis Diaz Rohena, PharmD
Malignant Hematology and Use of Bi-specifics in Puerto Rico
Malignant Hematology and Use of Bi-specifics in Puerto Rico
Alexis M. Cruz Chacón, MD FACP
Cancer Care Disparities in Puerto Rico (Part 1)
Cancer Care Disparities in Puerto Rico (Part 1)
Alexis M. Cruz-Chacon, MD, FACP
Diabetes Management in the Face of Healthcare Disparities
Diabetes Management in the Face of Healthcare Disparities
Katelyn O’Brien, PharmD, BCPS, CDCES, BC-ADM
Neurology Drug Update
Neurology Drug Update
Nicole Quiles Alves, PharmD, RPh, MPH & Hector J. Hernandez, PharmD, MPH, CSP
Role of Pharmacist in Vaccination: Challenges and Opportunities
Role of Pharmacist in Vaccination: Challenges and Opportunities
Ileana Rodriguez Nazario, PharmD
Sequencing Therapy in Relapsed/Refractory Myeloma Patients
Sequencing Therapy in Relapsed/Refractory Myeloma Patients
Craig Emmitt Cole, MD
Acquired Inhibitors in Cancer: State-of-the Art Management
Acquired Inhibitors in Cancer: State-of-the Art Management
Cindy Leissinger, MD
CAR-T Cell Therapy in Lymphomas: 7-Years Later
CAR-T Cell Therapy in Lymphomas: 7-Years Later
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP